Please login to the form below

Not currently logged in
Email:
Password:

World Bank approves USD 10m grant for HIV and AIDS prevention in Afghanistan

The World Bank has approved a USD 10m grant to support the Afghan government's efforts to prevent the transmission of HIV and AIDS in Afghanistan.

The World Bank has approved a USD 10m grant to support the Afghan government's efforts to prevent the transmission of HIV and AIDS in Afghanistan.

The HIV and AIDS Prevention Project aims to increase the country's capacity to respond to the disease by scaling up prevention programmes that target high-risk groups, including injecting drug users (IDU), long-distance lorry drivers, prisoners and sex workers.

The project will educate at risk groups about HIV prevention, strengthen surveillance of HIV cases and high-risk behaviour, map and estimate the size of groups engaged in high-risk behaviour and reduce the stigma of HIV and AIDS in the region.

A 2006 study found that three per cent of IDUs in Afghanistan's capital, Kabul, were HIV positive, while the number of officially recorded HIV cases in the country is 71, although UNAIDS and the World Health Organisation say that the number of HIV cases in Afghanistan is more likely to be in the 1,000 and 2,000 range.

6th August 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics